Amgen’s Otezla And BMS’s Sotyktu Battle For Share In Oral Psoriasis Drug Market

Q4 Was First Full Quarter BMS’s TYK2 Inhibitor Was Available

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.